XML 27 R13.htm IDEA: XBRL DOCUMENT v3.25.3
Note 6 - Fair Value Measurements
 9 Months Ended
Sep. 30, 2025
Notes to Financial Statements  
Fair Value Disclosures [Text Block]

Note 6 — Fair Value Measurements

 

The following table presents assets and liabilities reflected in the financial statements or disclosed in the notes to the financial statements at fair value on a recurring basis as of September 30, 2025 (in millions):

 

   

Fair value measurements using:

                  
   

Quoted prices

                                  
   

in active

    

Significant

                          
   

markets for

    

other

    

Significant

    

Investments

          
   

identical assets

    

observable

    

unobservable

    

valued at

          
   

and liabilities

    

inputs

    

inputs

    

practical

          
   

(Level 1)

    

(Level 2)

    

(Level 3)

    

expedient(1)

    

Total

  

Assets:

                                        

Cash equivalents

   $ 657.3     $ —     $ —     $ —     $ 657.3  

Current investments:

                                        

Consolidated VIEs

     515.8       551.7       —       —       1,067.5  

Other investments

     322.4       24.5       28.6       20.4       395.9  

Total current investments

     838.2       576.2       28.6       20.4       1,463.4  

Other

     —       2.3       2.8       —       5.1  

Total assets

   $ 1,495.5     $ 578.5     $ 31.4     $ 20.4     $ 2,125.8  

Liabilities:

                                        

Seed hedge derivatives

   $ —     $ 10.3     $ —     $ —     $ 10.3  

Long-term debt(2)

     —       404.8       —       —       404.8  

Deferred bonuses

     —       —       92.6       —       92.6  

Contingent consideration

     —       —       24.5       —       24.5  

Warrants

     —       26.0       —       —       26.0  

Other

     4.6       2.5       18.6       —       25.7  

Total liabilities

   $ 4.6     $ 443.6     $ 135.7     $ —     $ 583.9  

 

(1)   Certain seeded investment products that do not have a readily determinable fair value have been measured at fair value using the net asset value (“NAV”) as a practical expedient and have not been categorized in the fair value hierarchy. 
(2) Carried at amortized cost in our Condensed Consolidated Balance Sheets and disclosed in this table at fair value.

 ​

The following table presents assets and liabilities reflected in the financial statements or disclosed in the notes to the financial statements at fair value on a recurring basis as of  December 31, 2024 (in millions):

 

   

Fair value measurements using:

                  
   

Quoted prices

                                  
   

in active

    

Significant

                          
   

markets for

    

other

    

Significant

    

Investments

          
   

identical assets

    

observable

    

unobservable

    

valued at

          
   

and liabilities

    

inputs

    

inputs

    

practical

          
   

(Level 1)

    

(Level 2)

    

(Level 3)

    

expedient(1)

    

Total

  

Assets:

                                        

Cash equivalents

   $ 821.7     $ —     $ —     $ —     $ 821.7  

Current investments:

                                        

Consolidated VIEs

     260.6       241.5       —       —       502.1  

Other investments

     273.8       33.7       2.0       27.6       337.1  

Total current investments

     534.4       275.2       2.0       27.6       839.2  

Other

     —       10.2       2.5       —       12.7  

Total assets

   $ 1,356.1     $ 285.4     $ 4.5     $ 27.6     $ 1,673.6  

Liabilities:

                                        

Seed hedge derivatives

   $ —     $ 8.5     $ —     $ —     $ 8.5  

Long-term debt(2)

     —       383.3       —       —       383.3  

Deferred bonuses

     —       —       115.7       —       115.7  

Contingent consideration

     —       —       30.4       —       30.4  

Other

     1.9       3.2       —       —       5.1  

Total liabilities

   $ 1.9     $ 395.0     $ 146.1     $ —     $ 543.0  

 

(1)   Certain seeded investment products that do not have a readily determinable fair value have been measured at fair value using the NAV as a practical expedient and have not been categorized in the fair value hierarchy. 
(2) Carried at amortized cost in our Condensed Consolidated Balance Sheets and disclosed in this table at fair value.

 ​

Level 1 Fair Value Measurements

 

Our Level 1 fair value measurements consist mostly of investments held by consolidated and unconsolidated seeded investment products and cash equivalents with quoted market prices in active markets. The fair value level of consolidated investments held by seeded investment products is determined by the underlying securities of the product. The fair value level of most unconsolidated investments held in seeded investment products is determined by the NAV, which is considered a quoted price in an active market.

 

Level 2 Fair Value Measurements

 

Our Level 2 fair value measurements consist mostly of investments held by consolidated investment products and our long-term debt. The fair value level of consolidated investments held by seeded investment products is determined by the underlying securities of the product. The fair value level of our long-term debt is determined using recent trading activity, which is considered a Level 2 input.

 

Level 3 Fair Value Measurements

 

Investments

 

As of September 30, 2025, and December 31, 2024, certain investments within consolidated VIEs and VREs were valued using significant unobservable inputs, resulting in Level 3 classification.

 

Deferred Bonuses

 ​

Deferred bonuses represent liabilities to employees over the vesting period that will be settled by investments in our products or cash. Upon vesting, employees receive the value of the investment product selected by the participant, adjusted for gains or losses attributable to the product. The significant unobservable inputs used to value the liabilities are investment designations and vesting periods.

 

Changes in Fair Value

 

Changes in fair value of our Level 3 assets for the three and nine months ended September 30, 2025 and 2024, were as follows (in millions):

 

   

Three months ended

    

Nine months ended

  
   

September 30,

    

September 30,

  
   

2025

    

2024

    

2025

    

2024

  

Beginning of period fair value

   $ 25.3     $ 4.0     $ 4.5     $ 1.1  

Fair value adjustments

     2.5       (2.0 )     3.0       0.2  

Transfers from Level 1

     —       —       —       0.7  

Transfers from practical expedient

     —       —       9.4       —  

Purchases (sales) of securities, net

     3.6       11.8       14.5       11.8  

End of period fair value

   $ 31.4     $ 13.8     $ 31.4     $ 13.8  

 

Changes in fair value of our Level 3 liabilities for the three and nine months ended September 30, 2025 and 2024, were as follows (in millions):

 

   

Three months ended

    

Nine months ended

  
   

September 30,

    

September 30,

  
   

2025

    

2024

    

2025

    

2024

  

Beginning of period fair value

   $ 110.3     $ 76.3     $ 146.1     $ 117.6  

Fair value adjustments

     9.3       3.9       5.2       11.6  

Settlements

     (1.0 )     —       (1.6 )     —  

Vesting of deferred bonuses

     (1.0 )     0.1       (88.6 )     (84.2 )

Amortization of deferred bonuses

     18.2       18.4       51.3       53.9  

Foreign currency translation

     (0.1 )     2.2       2.7       2.0  

Additions

     —       4.4       20.6       4.4  

End of period fair value

   $ 135.7     $ 105.3     $ 135.7     $ 105.3  

 

Nonrecurring Fair Value Measurements

 

Nonrecurring Level 3 fair value measurements include goodwill, intangible assets and contingent consideration liabilities. We measure the fair value of goodwill and intangible assets on initial recognition based on the present value of estimated future cash flows. Significant assumptions used to determine the estimated fair value include assets under management (“AUM”), investment management fee rates, discount rates and expenses. We measure the fair value of contingent consideration liabilities on initial recognition using the Monte Carlo method, which requires assumptions regarding projected future earnings and the discount rate. Because of the significance of the unobservable inputs in the fair value measurements of these assets and liabilities, such measurements are classified as Level 3.

 

Investments Valued at Practical Expedient

 

As a practical expedient to value certain investments that do not have a readily determinable fair value and have attributes of an investment, we use the NAV as the fair value. As such, investments in private investment funds with a fair value of $20.4 million are excluded from the fair value hierarchy as of September 30, 2025. Further, the respective fund’s investment portfolio may contain debt investments that are in the form of revolving lines of credit and unfunded delayed draw commitments, which require the fund to provide funding when requested by portfolio companies in accordance with the terms of the underlying loan agreements. As of  September 30, 2025, the investments valued at the practical expedient had $3.5 million of associated unfunded commitments.